Osteopore Ltd (OSX) - Total Assets
Based on the latest financial reports, Osteopore Ltd (OSX) holds total assets worth AU$2.77 Million AUD (≈ $1.96 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check cash flow reinvestment rate of Osteopore Ltd to assess the company's total reinvestment commitment from operating cash flow.
Osteopore Ltd - Total Assets Trend (2016–2025)
This chart illustrates how Osteopore Ltd's total assets have evolved over time, based on quarterly financial data. Check Osteopore Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Osteopore Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Osteopore Ltd's total assets of AU$2.77 Million consist of 93.4% current assets and 6.6% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 22.6% |
| Accounts Receivable | AU$1.05 Million | 37.7% |
| Inventory | AU$362.86K | 13.1% |
| Property, Plant & Equipment | AU$183.40K | 6.6% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Osteopore Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see OSX market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Osteopore Ltd's current assets represent 93.4% of total assets in 2025, an increase from 75.6% in 2016.
- Cash Position: Cash and equivalents constituted 22.6% of total assets in 2025, up from 3.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 37.7% of total assets.
Osteopore Ltd Competitors by Total Assets
Key competitors of Osteopore Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
Bausch + Lomb Corp
TO:BLCO
|
Canada | CA$13.83 Billion |
|
Ocumetics Technology Corp
V:OTC
|
Canada | CA$1.15 Million |
Osteopore Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.85 | 0.86 | 7.78 |
| Quick Ratio | 0.73 | 0.72 | 7.66 |
| Cash Ratio | 0.21 | 0.23 | 0.00 |
| Working Capital | AU$-457.64K | AU$-368.36K | AU$8.49 Million |
Osteopore Ltd - Advanced Valuation Insights
This section examines the relationship between Osteopore Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 15.36 |
| Latest Market Cap to Assets Ratio | 0.63 |
| Asset Growth Rate (YoY) | -11.5% |
| Total Assets | AU$2.77 Million |
| Market Capitalization | $1.74 Million USD |
Valuation Analysis
Below Book Valuation: The market values Osteopore Ltd's assets below their book value (0.63x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Osteopore Ltd's assets decreased by 11.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Osteopore Ltd (2016–2025)
The table below shows the annual total assets of Osteopore Ltd from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | AU$2.77 Million ≈ $1.96 Million |
-11.50% |
| 2024-12-31 | AU$3.13 Million ≈ $2.22 Million |
-6.23% |
| 2023-12-31 | AU$3.34 Million ≈ $2.37 Million |
-7.66% |
| 2022-12-31 | AU$3.62 Million ≈ $2.56 Million |
-39.72% |
| 2021-12-31 | AU$6.01 Million ≈ $4.25 Million |
-41.39% |
| 2020-12-31 | AU$10.25 Million ≈ $7.25 Million |
+139.16% |
| 2019-12-31 | AU$4.28 Million ≈ $3.03 Million |
-20.68% |
| 2018-12-31 | AU$5.40 Million ≈ $3.82 Million |
+1445.09% |
| 2017-12-31 | AU$349.61K ≈ $247.37K |
-59.29% |
| 2016-12-31 | AU$858.80K ≈ $607.66K |
-- |
About Osteopore Ltd
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its tech… Read more